SORAFENIB IN HCC: REAL CLINICAL PRACTICE. LITERATURE REVIEW
I.I. Abdullin1, K.V. Menshikov1,2, A.V. Sultanbaev1,2, E.V. Popova1, O.N. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Abdullin Ilyas I. ― oncologist of the outpatient antitumor drug therapy department of the Republican Clinical Oncology Dispensary 73/1 Oktyabrya Ave., Ufa, 450054, Russian Federation, e-mail: ilyas.abdullin.99@mail.ru, ORCID ID: 0009-0009-8470-4606 Abstract. Currently, sorafenib is a … Читать далее